Skip to main content
Navigate Up
Sign In
 

Dr. Jimeno, New Member of Developmental Therapeutics Study Section

April 10th, 2018


Antonio Jimeno MD, PhD
​Congratulations to Dr. Jimeno on being selected to join the Developmental Therapeutics Study Section!

Detailed Letter:

It is my pleasure to inform you that Dr. Antonio Jimeno has accepted our invitation to serve as a member of the Developmental Therapeutics Study Section, Center for Scientific Review, for the term beginning July 01, 2018 and ending June 30, 2022.  Members are selected on the basis of their demonstrated competence and achievement in their scientific discipline as evidenced by the quality of research accomplishments, publications in scientific journals, and other significant scientific activities, achievements and honors.  Service on a study section also requires mature judgment and objectivity as well as the ability to work effectively in a group, qualities we believe Dr. Jimeno will bring to this important task.

 

As I am sure you know membership on a study section represents a major commitment of professional time and energy as well as a unique opportunity to contribute to the national biomedical research effort. Study sections review grant applications submitted to the NIH, make recommendations on these applications to the appropriate NIH national advisory council or board, and survey the status of research in their fields of science. These functions are of great value to medical and allied research in this country.

 

I want to take this opportunity to emphasize the importance of Dr. Jimeno’s participation in assuring the quality of the NIH peer review process, express the NIH appreciation of your institution's support of its activities, and indicate the hope and expectation that institutional officials will provide continued support.  You may wish to consider some form of recognition of Dr. Jimeno’s scientific stature and contributions, such as placing an article in your local newspaper.

 

Thank you again for your cooperation and support.


Sincerely,    
         

Richard Nakamura, Ph.D.
Director
Center for Scientific Review